Displaying 1 - 12 of 25

Display:

12 24 48

Immune-Mediated and Cholestatic Diseases

Albireo Pharma, an Ipsen Company: “New Horizons in cholestatic liver disease” (Complete Session)

Webcasts

View

Immune-Mediated and Cholestatic Diseases

Welcome and a journey back to 1992

Webcasts

View

Immune-Mediated and Cholestatic Diseases

Personal perspectives: What is the most significant advance in the last 10 years?

Webcasts

View

Immune-Mediated and Cholestatic Diseases

Snapshot in 2022 and beyond: Where are we now and what do we need to achieve?

Webcasts

View

Immune-Mediated and Cholestatic Diseases

Personal priorities

Webcasts

View

Immune-Mediated and Cholestatic Diseases

Welcome and introduction

Webcasts

View

Immune-Mediated and Cholestatic Diseases

PFIC in practice: Paediatric and adult case studies of patients with idiopathic cholestasis

Webcasts

View

Immune-Mediated and Cholestatic Diseases

Q&A

Webcasts

View

Immune-Mediated and Cholestatic Diseases

Unmet needs in PBC: the patient perspective

Webcasts

View

Immune-Mediated and Cholestatic Diseases

Welcome & objectives

Webcasts

View

Immune-Mediated and Cholestatic Diseases

Key considerations in the management of cirrhosis in PBC

Webcasts

View

Immune-Mediated and Cholestatic Diseases

Q&A

Webcasts

View

Displaying 1 - 12 of 25

Display:

12 24 48